About
Brain Imaging
Areas of Focus
Categories
Medical Imaging TechnologySoutheastern U.S.
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
2
As Collaborator
4
Total Enrollment
365
By Phase
PHASE2: 2EARLY_PHASE1: 1PHASE3: 2
By Status
NOT_YET_RECRUITING: 2RECRUITING: 1TERMINATED: 1UNKNOWN: 1COMPLETED: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT06907485Collaborator
A Multicenter Study to Assess the Feasibility of 5-Aminolevulinic Acid (5-ALA) in Pediatric Brain Tumor Patients
PHASE2Not yet recruiting
20 participants
Started: Dec 31, 2025 · Completed: Dec 31, 2027
NCT07038278Collaborator
5-AminoLevulinic Acid Aided Resection Margins in Sarcoma
EARLY_PHASE1Not yet recruiting
20 participants
Started: Dec 1, 2025 · Completed: Jul 1, 2028
NCT05804370Lead Sponsor
Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)
PHASE3Recruiting
170 participants
Started: May 30, 2024 · Completed: May 31, 2027
NCT05101798Collaborator
The Role of 5-Aminolevulinic Acid Fluorescence-Guided Surgery in Head and Neck Cancers: a Pilot Trial
PHASE2Terminated
7 participants
Started: Sep 14, 2021 · Completed: Dec 25, 2022
NCT04390802Collaborator
A Pilot Study of 5-Aminolevulinic Acid (5-ALA) to Enhance Visualization of Pituitary Adenomas
N/AUnknown
40 participants
Started: Jul 31, 2021 · Completed: Dec 31, 2021
Locations (1)
Headquarters
Lexington, KY, United States
Map
Loading map...